Perspective's promising PRRT trial results and solid financial position make CATX stock an attractive long-term investment ...
Learn about the promising Monopar Therapeutics Inc. MNPR-101 treatment targeting solid tumors and how it aims to reduce ...
StudyFinds on MSN13d
Scientists close to creating ‘simple pill’ that cures diabetesImagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...
Medpage Today on MSN9d
FDA Approves New IL-31 Drug for EczemaA monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...
anti-IL-7 Receptor Lusvertikimab in Ulcerative Colitis accepted for Oral Presentation and selected amongst the Top 10 oral ...
Merck (MRK) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP, adopted an opinion ...
HealthDay on MSN9d
American Society of Hematology, Dec. 7 to 10The annual meeting of the American Society of Hematology was held from Dec. 7 to 10 in San Diego and attracted participants ...
Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) for the treatment of patients 12 years and older with moderate-to-severe atopic dermatitis, in combination with topical ...
American Woman on MSN13d
Nicoya PuraTea Reviews (Morning Tea Hack For Weight Loss) Actually Works For Effective Results or Risky Side Effects?Nicoya PuraTea is a nutritional support intricately fabricated to support healthy weight loss. It uses selected ingred ...
UCB’s Novartis-partnered investigational small molecule has failed to improve symptoms of Parkinson’s disease in a phase 2a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback